Clinical Trial Update: Brain Dopaminergic Signaling in Opioid Use Disorders [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 clinical trial update from NIAAA examining brain dopaminergic signaling in opioid use disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Snippet

Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Conditions: Normal Physiology, Opioid Use Disorders | EARLY_Phase 1 | Status: COMPLETED